Literature DB >> 26843530

Gasping for answers. Focus on "Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia".

Ramon J Ayon1, Haiyang Tang1, Jason X-J Yuan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26843530      PMCID: PMC4796283          DOI: 10.1152/ajpcell.00017.2016

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  10 in total

1.  Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health).

Authors:  Virend K Somers; David P White; Raouf Amin; William T Abraham; Fernando Costa; Antonio Culebras; Stephen Daniels; John S Floras; Carl E Hunt; Lyle J Olson; Thomas G Pickering; Richard Russell; Mary Woo; Terry Young
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

2.  Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia.

Authors:  N Wang; H S Kang; G Ahmmed; S A Khan; V V Makarenko; N R Prabhakar; J Nanduri
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

3.  Obstructive Sleep Apnea in Patients with Congenital Long QT Syndrome: Implications for Increased Risk of Sudden Cardiac Death.

Authors:  Abu S Shamsuzzaman; Virend K Somers; Timothy K Knilans; Michael J Ackerman; Yu Wang; Raouf S Amin
Journal:  Sleep       Date:  2015-07-01       Impact factor: 5.849

4.  The effect of sleep apnea on QT interval, QT dispersion, and arrhythmias.

Authors:  Kitti Barta; Zoltán Szabó; Csaba Kun; Csaba Munkácsy; Orsolya Bene; Mária Tünde Magyar; László Csiba; István Lörincz
Journal:  Clin Cardiol       Date:  2010-06       Impact factor: 2.882

5.  Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome.

Authors:  Qiuming Gong; Li Zhang; G Michael Vincent; Benjamin D Horne; Zhengfeng Zhou
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

6.  Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities.

Authors:  Jayasri Nanduri; Ning Wang; Guoxiang Yuan; Shakil A Khan; Dangjai Souvannakitti; Ying-Jie Peng; Ganesh K Kumar; Joseph A Garcia; Nanduri R Prabhakar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

Review 7.  hERG K(+) channels: structure, function, and clinical significance.

Authors:  Jamie I Vandenberg; Matthew D Perry; Mark J Perrin; Stefan A Mann; Ying Ke; Adam P Hill
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

8.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

Authors:  M E Curran; I Splawski; K W Timothy; G M Vincent; E D Green; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

10.  Mitochondrial reactive oxygen species mediate hypoxic down-regulation of hERG channel protein.

Authors:  Jayasri Nanduri; Ning Wang; Pamela Bergson; Guoxiang Yuan; Eckhard Ficker; Nanduri R Prabhakar
Journal:  Biochem Biophys Res Commun       Date:  2008-06-18       Impact factor: 3.575

  10 in total
  1 in total

1.  Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia.

Authors:  N Wang; H S Kang; G Ahmmed; S A Khan; V V Makarenko; N R Prabhakar; J Nanduri
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.